Detalhe da pesquisa
1.
Plasma Progerin in Patients With Hutchinson-Gilford Progeria Syndrome: Immunoassay Development and Clinical Evaluation.
Circulation
; 147(23): 1734-1744, 2023 06 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36919608
2.
Quantifying the Release of Biomarkers of Myocardial Necrosis from Cardiac Myocytes and Intact Myocardium.
Clin Chem
; 63(5): 990-996, 2017 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-28377413
3.
Biomarkers in fasting serum to estimate glucose tolerance, insulin sensitivity, and insulin secretion.
Clin Chem
; 57(2): 326-37, 2011 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-21149503
4.
Generation of PEGylated VPAC1-selective antagonists that inhibit proliferation of a lung cancer cell line.
Peptides
; 29(3): 479-86, 2008 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-17942192
5.
A potent and highly selective VPAC2 agonist enhances glucose-induced insulin release and glucose disposal: a potential therapy for type 2 diabetes.
Diabetes
; 51(5): 1453-60, 2002 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-11978642
6.
Clinically significant novel biomarkers for prediction of first ever myocardial infarction: the Tromsø Study.
Circ Cardiovasc Genet
; 8(2): 363-71, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25613532
7.
Microfluidic strategies applied to biomarker discovery and validation for multivariate diagnostics.
Bioanalysis
; 3(19): 2233-51, 2011 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-21985417
8.
Development of a type 2 diabetes risk model from a panel of serum biomarkers from the Inter99 cohort.
Diabetes Care
; 32(7): 1207-12, 2009 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-19564473
9.
Generation of highly selective VPAC2 receptor agonists by high throughput mutagenesis of vasoactive intestinal peptide and pituitary adenylate cyclase-activating peptide.
J Biol Chem
; 278(12): 10273-81, 2003 Mar 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-12525492